Literature DB >> 19357719

A urinary biomarker profile for children with HIV-associated renal diseases.

Angel A Soler-García1, Natella Y Rakhmanina, Parnell C Mattison, Patricio E Ray.   

Abstract

Human immunodeficiency virus (HIV)-infected children are at risk of developing several types of renal diseases, including HIV-associated nephropathy (HIVAN), which is usually seen during late stages of infection in children with a high viral load. This disease is defined by the presence of proteinuria associated with mesangial hyperplasia and/or global-focal segmental glomerulosclerosis combined with microcystic transformation of the renal tubules. Because HIVAN can have an insidious clinical onset, renal biopsy is the only definitive way of establishing a diagnosis. Given the risk of performing this procedure in HIV-infected children with other AIDS-defining illness, we sought to identify informative biomarkers such as growth factors in the urine of 55 HIV-infected children that might be predictive of the extent and activity of the renal lesions characteristic of HIVAN. We found that the levels of epidermal growth factor were lower in the urine of children with renal disease, whereas levels of fibroblast growth factor-2 and metalloproteinase-2 were higher as compared with those levels in infected children without renal disease. Similar changes were observed in HIV-Tg26 mice correlating with the progression of renal disease in this model of HIVAN. Our findings suggest that this urinary growth factor profile may be useful in facilitating the diagnosis of HIV-infected children at risk of developing HIVAN when interpreted in the appropriate clinical setting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357719      PMCID: PMC2778294          DOI: 10.1038/ki.2009.115

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  45 in total

1.  Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney.

Authors:  S Horikoshi; S Kubota; G R Martin; Y Yamada; P E Klotman
Journal:  Kidney Int       Date:  1991-01       Impact factor: 10.612

2.  Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability.

Authors:  G Ascherl; C Sgadari; R Bugarini; J Bogner; O Schatz; B Ensoli; M Stürzl
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-20       Impact factor: 2.205

3.  Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome.

Authors:  Patricio E Ray; Elena Tassi; Xue-Hui Liu; Anton Wellstein
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-01       Impact factor: 3.619

4.  Expression of epidermal growth factor receptor and proliferative activity of cyst epithelium in human renal cystic diseases.

Authors:  Eva Compérat; Sophie Ferlicot; Philippe Camparo; Pascal Eschwege; Nathalie Ba; Gérard Benoit; Pierre Bédossa; Valérie Paradis
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

5.  Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy.

Authors:  T Sasaki; Y Jyo; N Tanda; Y Kawakami; T Nohno; H Tamai; G Osawa
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

6.  Basic fibroblast growth factor in HIV-associated hemolytic uremic syndrome.

Authors:  P E Ray; X H Liu; L Xu; T Rakusan
Journal:  Pediatr Nephrol       Date:  1999-09       Impact factor: 3.714

Review 7.  Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.

Authors:  Cecilia Sgadari; Paolo Monini; Giovanni Barillari; Barbara Ensoli
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

8.  Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues.

Authors:  L B Rall; J Scott; G I Bell; R J Crawford; J D Penschow; H D Niall; J P Coghlan
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

9.  Molecular identification of SV40 infection in human subjects and possible association with kidney disease.

Authors:  Rui-Mei Li; Mary H Branton; Somsak Tanawattanacharoen; Ronald A Falk; J Charles Jennette; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

10.  Characterization of primary rabbit kidney cultures that express proximal tubule functions in a hormonally defined medium.

Authors:  S D Chung; N Alavi; D Livingston; S Hiller; M Taub
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  14 in total

1.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

2.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

Review 3.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

4.  The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.

Authors:  Xuefang Xie; Anamaris M Colberg-Poley; Jharna R Das; Jinliang Li; Aiping Zhang; Pingtao Tang; Marina Jerebtsova; J Silvio Gutkind; Patricio E Ray
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

5.  A pilot study of urinary fibroblast growth factor-2 and epithelial growth factor as potential biomarkers of acute kidney injury in critically ill children.

Authors:  Kitman Wai; Angel A Soler-García; Sofia Perazzo; Parnell Mattison; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2013-07-20       Impact factor: 3.714

6.  Renal abnormalities in a cohort of HIV-infected children and adolescents.

Authors:  Flávia Vanesca Felix Leão; Regina Célia de Menezes Succi; Daisy Maria Machado; Aída de Fátima Thomé Barbosa Gouvêa; Fabiana Bononi do Carmo; Suenia Vasconcelos Beltrão; Maria Aparecida de Paula Cançado; João Tomas de Abreu Carvalhaes
Journal:  Pediatr Nephrol       Date:  2015-12-04       Impact factor: 3.714

Review 7.  Renal transplantation in human immunodeficiency virus (HIV)-positive children.

Authors:  Mignon I McCulloch; Udai K Kala
Journal:  Pediatr Nephrol       Date:  2014-04-02       Impact factor: 3.714

8.  A novel urinary biomarker profile to identify acute kidney injury (AKI) in critically ill neonates: a pilot study.

Authors:  Suma Bhat Hoffman; An N Massaro; Angel A Soler-García; Sofia Perazzo; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2013-06-20       Impact factor: 3.714

Review 9.  Urinary Markers of Tubular Injury in HIV-Infected Patients.

Authors:  Temesgen Fiseha; Angesom Gebreweld
Journal:  Biochem Res Int       Date:  2016-07-17

10.  Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.

Authors:  Jharna R Das; J Silvio Gutkind; Patricio E Ray
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.